Cure with Quality of Life
Our mission is to deliver the highest quality care, support and technology to the physician and the patient. HIFU Solution was founded to provide men access to a noninvasive treatment option for prostate cancer. Being diagnosed with prostate cancer can be stressful and confusing. Studies have shown emotional distress and anxiety can provoke men and their loved ones into choosing surgery as treatment instead of less invasive options.
The ASTRO/AUA Guidelines published in 2017 provides directions to clinicians and patients regarding the use of various treatments based on evidence based and consensus-based processes. The most effective approach for a particular patient is best determined by discussion among a multi-disciplinary team of physicians, the patient and the family. The AUA Guidelines recommend the
discussion regarding treatment take into account considerations of complications, adverse effects, relative efficacy, and quality of life issues. Health–Related quality of life is a particulary important concern for patient with clinically localized prostate cancer.
Both radical and surgery and all forms of radiation leave men with major complications.
HIFU gives men the option to choose curative treatment with less complications and better quality of life.
At present, HIFU is limited by the fact that no randomized studies have been completed comparing HIFU with surgery or radiation. Randomized studies comparing HIFU to surgery are currently on going.
What we do know is that based on available data with 10-15 years follow-up, the French, German, and Japanese experience with HIFU is good. HIFU results are comparable to surgery and radiation with less side effects.
For more click the buttons below!
Rigorous Training and Data Collection for Patient Safety
Patients safety is at the heart of our surgical training and quality outcomes. At HIFU Solution, we insist on rigorous training of our physicians. We are constantly innovating training techniques as well as skills associated with study, clear thinking, and advanced planning. To achieve good results we have developed concepts which include analysis of data that is constantly updated based on new clinical trials and
publications. We have a team of academic physicians who advise and assist our community physicians at various locations to perform HIFU. We also document our results and modify our surgical approach based on experience.
HIFU Solution delivers, on a national basis, mobile High Intensity Focused Ultrasound (“HIFU”) devices, both Ablatherm and Sonablate, to medical facilities where a physician conducts each prostate ablation procedure. A dedicated, highly trained HIFU technologist assists with operation of the equipment.
HIFU Solution provides qualified and international proctors who have completed Phase 1,2 and 3 training and are experienced in doing HIFU procedures in patients for a variety of cancer types including whole gland, focal, hemi, subtotal, radiation failures, and high grade cancers.These experienced proctors can help the physician starting HIFU training, have access to the world’s best doctors including University-trained physicians at academic centers experienced in HIFU with ability to treat patients with various types of prostate cancer. HIFU Solution is the only national company with contracts at university centers in various parts of the country. The availability of highly skilled academic physicians along with HIFU Solution's international training program gives healthcare providers access to the latest HIFU technology and cutting edge treatments. Most physician groups in private practice cannot afford the costs associated with ongoing physician education, purchasing and maintaining of equipment, replacing technology when it becomes obsolete, and training support staff. HIFU Solution provides Phase 1,2 and3 training at present at no cost to urologists interested in HIFU training. HIFU Solution, LLC mobile medical technology enables doctors and surgery centers of any size, from comprehensive medical centers to offices in remote or rural communities, to provide a wider array of treatment options for prostate cancer.